XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparibReem Ali, Srinivasan Madhusudan, Michael S. Toss et al.|Therapeutic Advances in Medical Oncology|2020Cited by 26